topiramate tablet, film coated
apotheca inc. - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 100 mg - topiramate tablets, usp are indicated as initial monotherapy in patients 2 years of age and older with partial onset or primary generalized tonic-clonic seizures. safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials [see clinical studies ( 14.1)] . topiramate tablets, usp are indicated as adjunctive therapy for adults and pediatric patients ages 2 to 16 years with partial onset seizures or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with lennox-gastaut syndrome [see clinical studies ( 14.2)] . additional pediatric use information for patients ages 12 to 17 years is approved for janssen pharmaceuticals, inc.’s topamax (topiramate) tablets and sprinkle capsules. however, due to janssen pharmaceuticals, inc.’s marketing exclusivity rights,
tizanidine 2mg tablets
phoenix healthcare distribution ltd - tizanidine hydrochloride - oral tablet - 2mg
tizanidine 4mg tablets
phoenix healthcare distribution ltd - tizanidine hydrochloride - oral tablet - 4mg
clarithromycin 500mg tablets
phoenix healthcare distribution ltd - clarithromycin - oral tablet - 500mg
ropinirole 5mg tablets
phoenix healthcare distribution ltd - ropinirole hydrochloride - oral tablet - 5mg
topiramate tablet
apotheca inc. - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topiramate 50 mg - topiramate tablets, usp are indicated as initial monotherapy in patients 2 years of age and older with partial onset or primary generalized tonic-clonic seizures. safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials [see clinical studies ( 14.1)] . topiramate tablets, usp are indicated as adjunctive therapy for adults and pediatric patients ages 2 to 16 years with partial onset seizures or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with lennox-gastaut syndrome [see clinical studies ( 14.2)] . additional pediatric use information for patients ages 12 to 17 years is approved for janssen pharmaceuticals, inc.’s topamax (topiramate) tablets and sprinkle capsules. however, due to janssen pharmaceuticals, inc.’s marketing exclusivity rights,
phoenix clinical icon ophthalmic imaging system
excimed (s) pte. ltd. - ophthalmology - the phoenix clinical icon ophthalmic imaging system is indicated for general ophthalmic imaging including retinal, corneal, and external structures of the eye.
phoenix paracetamol plus tablet
phoenix chemicals laboratory (bd) ltd. - caffeine + paracetamol - tablet - 65 mg + 500 mg
phoenix ketorolac tablet
phoenix chemicals laboratory (bd) ltd. - ketorolac tromethamine - tablet - 10 mg
phoenix seabuckthorn extract softgel
phoenix nutrifresh sdn bhd - hippophae rhamnoides (sea buckthorn) seed oil; hippophae rhamnoides (sea buckthorn) berry oil -